MedPath

Simponi

Brand Name: Simponi

Generic Name: Golimumab

Active
Registration Number

BR-906

Dosage Form

Solution For Injection (SC)

Issuance Date

March 15, 2022

Expiry Date

May 14, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/0.5 mL
PackagingPre-filled pen (Smartject) x 0.5 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

GolimumabActive
Monograph: Golimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform